Company Announcements

Notice of Interim Results & Investor Presentation

Source: RNS
RNS Number : 3695G
Carclo plc
15 November 2022
 

15 November 2022

 

Carclo plc

 

Notice of Interim Results and Investor Presentation

 

Carclo plc will announce its Interim Results for the period ended 30 September 2022 at 7.00 am on Wednesday 30 November 2022.

 

Frank Doorenbosch, Chief Executive Officer, and David Bedford, Chief Financial Officer, will provide a live presentation relating to the Interim Results for the period ended 30 September 2022 via the Investor Meet Company platform on 30 November 2022 at 10.00 am (GMT). 

 

The presentation is open to all existing and potential shareholders.  Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00 am (GMT) the day before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet Carclo plc via the following link:

 

https://www.investormeetcompany.com/carclo-plc/register-investor

Investors who already follow Carclo plc on the Investor Meet Company platform will be invited automatically.

 

 

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. The Group is a global provider of value-adding engineered solutions for the medical, optical and aerospace industries.

 

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc

01924 268040

Frank Doorenbosch - Chief Executive Officer


David Bedford - Chief Financial Officer




FTI Consulting

020 3727 1340

Nick Hasell / Susanne Yule


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOREAPFLFLKAFFA